KSHB: Local Woman Among First to Receive Innovative Treatment Combination for Metastatic Breast Cancer

In 2021, Lori Anderson was diagnosed with stage 2B triple-negative breast cancer. An aggressive form of breast cancer, Lori was told she might have only two to five more years of life.

At the Saint Luke’s Hospital Koontz Center for Advanced Breast Cancer, Lori sought treatment and guidance from a multidisciplinary team led by Dr. Timothy Pluard, the center’s medical director.

Now in 2026, after opting for an innovative combination of an immunotherapy drug and a new treatment called an antibody-drug conjugate, Lori's scans show no evidence of metastatic disease.

Lori and Dr. Pluard talked with KSHB  about the new treatment and how its expanding treatment options for people facing aggressive forms of cancer.